![](/img/cover-not-exists.png)
How many people develop anti-drug antibodies to the biologic drug tildrakizumab, and what impact does this have on the effectiveness of their treatment
Kimball, A.B., Kerbusch, T., van Aarle, F., Kulkarni, P., Li, Q., Blauvelt, A., Papp, K.A., Reich, K., Montgomery, D.Volume:
182
Journal:
British Journal of Dermatology
DOI:
10.1111/bjd.18662
Date:
January, 2020
File:
PDF, 75 KB
2020